HTML
Droplet Digital PCR is the perfect tool to detect gene-modified cells in different body fluids. Immunotherapy with CD19-specific CAR-T cells has shown excellent efficacy in late-stage relapsed/refractory B-cell cancers. In vivo expansion and persistence of CAR-T cells after infusion are important responses and toxicity determining variables, but diagnostic tools are largely missing. Join us for our webinar where Dr. Fehse talks us through his research about how ddPCR is excellently suited as a diagnostic tool to monitor infused cells in real-time in different body fluids.